Confirmation of array results by qRT-PCR, and the detection of areal- and cell type-restricted expression patterns by ISH and IHC.
(A–C) NPY enrichment in non-frontal areas is confirmed by qRT-PCR, with highest expression in temporal (TAS, TAU) and occipital lobes (OCC). (B) ISH on a whole sagittal section of 24 wg human brain confirms NPY enrichment in OCC. NPY enrichment in temporal cortex is not visible in this very medial tissue section. (C) Higher magnification reveals specific enrichment in the middle of the occipital cortical plate (CP), and high expression in scattered cells throughout the subplate (SP) (red arrowheads).
(D–F) CBLN2 enrichment in OPFC and lateral PFC is confirmed by qRT-PCR (D) and ISH on a whole sagittal section of 24 wg brain (E). (F) Higher magnification reveals that CBLN2 is enriched throughout the prefrontal CP and SP, but absent from the marginal zone (MZ).
(G–I) CNTNAP2 is selectively enriched in OPFC and lateral PFC areas. (H–I) IHC reveals specific diffuse enrichment in orbitofrontal SP and high expression in scattered MZ cells. Triple-immunofluorescent staining (I, middle panel) reveals colocalization of CNTNAP2 with astrocytic marker GFAP but not neuronal marker NeuN, suggesting differential expression of CNTNAP2 in SP astrocytes.
(J–L) FOXP2 is differentially expressed within the frontal cortex, and enriched in perisylvian cortex. IHC in coronal 22 wg brain sections (K–L) suggests that these differences are accounted for by a combination of higher cellular expression levels in the CP, particularly in OPFC (lower insets), and greater numbers of FOXP2-immunopositive SP cells, especially in VLPFC and PAS. Interestingly, strongly FOXP2-positive cells were present in the MZ in VLPFC and OPFC, but were completely absent from the MZ in other areas (upper insets). Bar graphs are mean±SEM. Scale bars in C, F, I, L: 500 µm.